Bell Investment Advisors’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$811 Hold
32
﹤0.01% 1591
2026
Q1
$685 Hold
32
﹤0.01% 1637
2025
Q4
$685 Hold
32
﹤0.01% 1643
2025
Q3
$536 Hold
32
﹤0.01% 1740
2025
Q2
$460 Hold
32
﹤0.01% 1779
2025
Q1
$464 Hold
32
﹤0.01% 1782
2024
Q4
$420 Sell
32
-34
-52% -$469 ﹤0.01% 1826
2024
Q3
$765 Hold
66
﹤0.01% 1671
2024
Q2
$499 Hold
66
﹤0.01% 1819
2024
Q1
$662 Hold
66
﹤0.01% 1724
2023
Q4
$614 Hold
66
﹤0.01% 1754
2023
Q3
$839 Hold
66
﹤0.01% 1625
2023
Q2
$938 Sell
66
-34
-34% -$477 ﹤0.01% 1614
2023
Q1
$1.49K Buy
100
+69
+223% +$1.04K ﹤0.01% 1401
2022
Q4
$461 Buy
31
+1
+3% +$16 ﹤0.01% 1877
2022
Q3
$0 Sell
30
-22
-42% -$443 ﹤0.01% 1862
2022
Q2
$1K Buy
+52
New +$1.06K ﹤0.01% 1493

Other funds holding MD

Bell Investment Advisors's MD Position: Q2 2026 in Review

Bell Investment Advisors held its Pediatrix Medical (MD) position steady in Q2 2026 at 32 shares worth $811. The position accounts for ﹤0.01% of the portfolio, ranked #1591.

Bell Investment Advisors first reported a position in MD in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.49K in Q1 2023. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Bell Investment Advisors held 32 shares of Pediatrix Medical worth $811 as of Q2 2026.
  • Bell Investment Advisors left its Pediatrix Medical share count unchanged in Q2 2026.
  • Pediatrix Medical made up ﹤0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #1591 holding.
  • Bell Investment Advisors first reported a position in Pediatrix Medical in Q2 2022 and has held it in 17 quarters since.
  • Bell Investment Advisors's Pediatrix Medical position peaked at $1.49K in Q1 2023.
  • 304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.